Mixed connective tissue disease (MCTD) is an uncommon inflammatory autoimmune disorder that involves symptoms of several other complex diseases. There’s no specific treatment for this condition as the symptoms don’t appear at once. They tend to happen over the years, which makes diagnosis harder. 

Thus, the treatment for each person varies depending on their symptoms and the severity of their condition. Keep reading for a detailed analysis of MCTD.

What is Mixed Connective Tissue Disease?

MCTD is a rare autoimmune condition in which the immune system attacks healthy tissues, causing overlapping symptoms of lupus, scleroderma, and polymyositis. It most commonly affects women between 20 and 50 years of age.

Mixed connective tissue disease is a rare autoimmune disorder where the body’s immune system misunderstands its own body tissues as invaders and attacks them. It is characterised by the presence of specific antibodies in the blood, especially anti-U1 ribonucleoprotein (RNP) antibodies.

MCTD features the symptoms of three other connective tissue diseases:

• Systemic lupus erythematosus (SLE)
• Scleroderma
• Polymyositis

Some people also suffer from dermatomyositis, rheumatoid arthritis, or Sjogren’s syndrome. Around 25% of people suffering from MCTD also develop another connective tissue disorder over the course of a few years.

Therefore, it is commonly referred to as ‘overlap syndrome’. It mainly affects females between the ages of 20 and 50, but people of all age groups, including children, can also develop MCTD.

What are the Causes of Mixed Connective Tissue Disease?

The actual cause of MCTD is not known yet, but it is linked to genetic and environmental factors. Viral infections, chemical exposure, and a family history of autoimmune diseases may increase the risk.

While the exact cause of MCTD remains unknown, some research shows that environmental and genetic factors trigger the disease.

Here are a few identified causes of MCTD:

• Environmental Causes 

Some studies have shown that environmental factors, such as exposure to certain viruses or chemicals, can trigger MCTD in genetically predisposed individuals.

For instance, viral infections like the Epstein-Barr virus (EBV), frequent exposure to chemicals or materials, like polyvinyl chloride and silica, are linked to the onset of autoimmune diseases.

• Genetic Causes

Research has found that genetic propensity plays a significant role in the development of MCTD. Past data show that individuals with a family history of autoimmune diseases are at an elevated risk of developing MCTD.

Certain genes linked to immune system regulation may increase the likelihood of developing MCTD.

What are the Risk Factors of Mixed Connective Tissue Disease?

MCTD’s risk is higher in women aged from 15 to 50 and in individuals with a history of autoimmune diseases. Other factors, such as geographical location, unhealthy lifestyle habits, poor diet, stress, smoking, and low physical activity, may increase the severity of the condition.

Apart from these causes, studies and past statistics have suggested a few other factors that elevate the risk of developing MCTD:

• Age and Gender: The symptoms of MCTD are most likely to be found in individuals between the ages of 15 and 50. Women are more susceptible to the disease than men, with a ratio of around 8:1.
• Geographical Area: Few studies have shown that people living in certain geographical locations are more prone to the disease, but more evidence is required on this.
• Underlying Conditions: Individuals with other autoimmune conditions, like rheumatoid arthritis, lupus, etc, are at a higher risk of developing MCTD.
• Lifestyle Factors: Dietary choices and lifestyle habits can also contribute to the risk of developing MCTD. Highly processed foods and low antioxidants in the diet are key factors that contribute to inflammation. Excessive stress, lack of physical exercise, and smoking are some habits that can aggravate autoimmune conditions.

While these factors can’t be directly associated with MCTD, they can increase the severity and progression of the disorder.

What are the Symptoms of Mixed Connective Tissue Disease? 

MCTD causes overlapping symptoms that vary in severity from person to person. Common signs include chronic fatigue, joint pain and swelling, muscle weakness, skin rashes, and breathing or swallowing difficulties.

MCTD shows overlapping symptoms that vary from person to person and also depend on the severity of their condition. The common symptoms of the disorder include:

• Fatigue and Tiredness 

The most common symptoms of MCTD are chronic fatigue and feeling sick, including mild fever at times. The person will feel unwell most of the time.

• Swelling and Pain

People experience swelling in their hands and fingers along with sudden joint pain. The shape of the joints may change, and they become irritated and inflamed. The blood flow to your fingers, toes, ears, and nose is affected, causing sensitivity, numbness, and loss of colour in these areas.

This is also called Raynaud’s disease, in which fingers and toes become cold and numb and can even turn white or grey in response to stress. After warming, they may turn red. These symptoms are harder to notice depending on the skin colour.

• Muscle Weakness

Patients experience muscle weakness, particularly in the upper arms and thighs. Muscles become tender, leading to severe pain and discomfort.

• Skin Problems

MCTD is also characterised by several skin issues, like rashes and irritation. It features mostly red or brown patches over the knuckles, specifically a butterfly-shaped rash across the cheeks and nose. These signs are also harder to notice at the onset of the disorder.

• Difficulty in Breathing

People often complain about a persistent cough and shortness of breath. Involvement of the oesophagus may also cause difficulty swallowing (dysphagia).

How is Mixed Connective Tissue Disease Diagnosed?

MCTD is diagnosed through a step-by-step evaluation of symptoms, medical history, and physical findings. Doctors confirm the condition using blood tests for anti-U1 RNP, along with urine tests, imaging studies, and sometimes a biopsy.

MCTD can be diagnosed in several steps because it presents overlapping symptoms. The healthcare professionals begin with a clinical evaluation assessing symptoms, family health history, and underlying conditions (if any) of the patients, and then proceed to other lab tests if they suspect MCTD.

Several diagnostic tests are carried out to confirm the diagnosis of MCTD:

• Blood Tests: The presence of several antibodies can be confirmed through blood tests. The presence of anti-U1 RNP antibodies is a key indicator of MCTD. However, doctors also check for other antibodies, such as antinuclear antibodies (ANAs) and antiribonucleoprotein antibodies (anti-RNP antibodies).

The presence of these autoantibodies is mandatory for the diagnosis of MCTD, but not all people with these antibodies have the disorder. In addition, the doctor may also prescribe CBC (Complete Blood Count) and ESR (Erythrocyte Sedimentation Rate) to assess the degree of inflammation in the patient.

• Urine Tests: These tests are carried out to check the overall health and functioning of the kidneys.
• Imaging Tests: In cases of severe joint problems, the doctor may prescribe X-rays, CT (computed tomography) scans, or MRIs (magnetic resonance imaging) to assess joint involvement or involvement of other organs in MCTD.
• Biopsy: Since MCTD shows overlapping symptoms in some cases, doctors require a biopsy of the affected connective tissue to rule out other conditions.

What are the Possible Complications of Mixed Connective Tissue Disease?

MCTD can lead to serious complications if not managed properly. These include lung and heart problems, infections, kidney and digestive issues, dental problems, and pulmonary hypertension.

MCTD can have several short-term and long-term complications on your health. These can be serious and fatal at times. Here are several complications that MCTD brings, depending on the severity of your condition:

• Pulmonary Hypertension: It refers to increased blood pressure in the lungs, which can lead to heart failure and death. It is one of the major causes of death among people suffering from MCTD.
• Interstitial Lung Disease: MCTD is a large group of disorders that lead to scarring in the lungs, causing difficulty breathing. People may require regular oxygen for treatment.
• Infections: People with MCTD often experience multiple infections due to immunosuppressive treatment, which weakens their immune system.
• Cardiac Issues: It can cause swelling, irritation, and inflammation around the heart. Parts of the heart become larger and may not function well, which will increase the risk of heart failure and stroke.
• Kidney Damage: Rarely, people with MCTD experience kidney problems that are mild and can be controlled. However, if the disorder continues for a long time, it can cause kidney damage.
• Digestive Tract Damage: MCTD often affects the long tube of organs that are responsible for digestion. This can cause heartburn, stomachache, and difficulty in swallowing foods and liquids.
• Gangrene: People with serious symptoms of Raynaud’s disorder may experience death of tissues in their fingertips, which causes swelling and hardening of the fingers.
• Hearing Loss: A small study has revealed that almost half of the people with MCTD suffer hearing loss. However, more evidence is yet to be found on this link.
• Dental Issues: Many people with MCTD develop Sjogren syndrome, a disorder that can be a part of MCTD. It causes dental issues, dry mouth, and loss of teeth.

What are the Treatment Options for Mixed Connective Tissue Diseases?

Treatment for MCTD focuses on controlling symptoms and preventing organ damage. Depending on severity, doctors may prescribe corticosteroids, antimalarial drugs, immunosuppressants, and medicines for lung or blood pressure complications.

There is no permanent cure for MCTD. Medications help lower the symptoms and improve the quality of life. The type of medication depends on the organs affected and the severity of the condition, which can include:

• Corticosteroids

Low-dose corticosteroid medications like Prednisone are prescribed to manage mild symptoms of MCTD. It helps reduce inflammation and prevents the immune system from attacking healthy tissues.

However, prolonged use of these medicines can increase the risk of high blood pressure, infections, and weakened bones.

• Antimalarial Drugs

Medicines such as hydroxychloroquine (Plaquenil, Sovuna) are used to reduce symptoms of mild mixed connective tissue disorder. It mostly helps to prevent flare-ups.

• Calcium Channel Blockers

These medications (nifedipine and amlodipine) are given to people with Raynaud’s syndrome to help relax the muscles in the walls of blood vessels.

• Immunosuppressants

If major organs are affected by MCTD, the doctor might prescribe immunosuppressant drugs such as azathioprine or methotrexate to reduce your immune system’s activity and prevent organ damage.

• Nonsteroidal Anti-Inflammatory Drugs (NSAIDs)

These medications are mainly given to ease joint pain and inflammation.

• Antihypertensive Medicines

MCTD can lead to high blood pressure in the lungs(pulmonary hypertension). In that case, your doctor may prescribe antihypertensive drugs such as bosentan and or sildenafil to manage this condition.

• Medicines for Lung Disorders

In some cases, MCTD leads to lung scarring (interstitial lung disease). Treatment or medications can’t reverse it, but the doctor prescribes corticosteroids and other medicines to reduce the progression of the condition.

FAQs about Mixed Connective Tissue Disease 

1. Is MCTD curable?

Presently, there is no cure for MCTD, but its symptoms can be managed with effective treatment and healthy habits. Many people manage to live a fulfilling life by controlling the symptoms through medicines.

2. Can MCTD affect my quality of life?

Mild symptoms of MCTD are easy to manage, but chronic symptoms can lead to potential long-term complications and hamper your quality of life.

With early diagnosis and an effective treatment plan, individuals can manage the symptoms and maintain a good quality of life.

3. What is the life expectancy of a person with MCTD?

The life expectancy of people with MCTD depends on the severity of their conditions and the organs affected.

Most of the deaths are caused by pulmonary hypertension, kidney failure, or heart failure. However, with effective treatment, the 10-year survival rate for MCTD is around 80%.

4. Can lifestyle changes help manage MCTD?

Yes, lifestyle changes can help manage the symptoms of MCTD. Regular physical exercise, a healthy diet, and stress management techniques can help to improve your overall quality of life.

5. What are the early signs of MCTD?

Early signs of MCTD can include joint pain, swelling of fingers and toes, skin problems, muscle weakness, and fatigue. It is important to consult a doctor immediately, as early diagnosis is the only way to avoid severe MCTD symptoms.

Conclusion

Mixed connective tissue disease is a complex autoimmune condition that features the symptoms of multiple autoimmune disorders. Since there is no cure for this condition, early diagnosis and proper management can save the vital organs from being affected.

To understand more such complex NEET PG concepts, DocTutorials can be your study partner. We offer crisp videos, clinical Qbank, exam-focused notes, flashcards, and mindmaps to help aspirants gain clarity on every medical concept.

Join DocTutorials today and explore our NEET PG course to excel in your medical career!